초록

The invention relates to an orally administrable chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester.

대표청구항 ▼

1. An orally administrable chewable composition in unit dosage form comprising a chewable, set, oil-in-water emulsion, in which the aqueous phase is gelled and constitutes about 50% to 60% wt. of the unit dosage form and in which the unit dosage from comprises about 40% wt. of a fish oil, wherein sa

1. An orally administrable chewable composition in unit dosage form comprising a chewable, set, oil-in-water emulsion, in which the aqueous phase is gelled and constitutes about 50% to 60% wt. of the unit dosage form and in which the unit dosage from comprises about 40% wt. of a fish oil, wherein said aqueous phase comprises gelatin in an amount of about 10% to 25% wt. of the aqueous phase, and wherein the unit dosage form has an overall dose unit weight of 0.25 to 3 g, and wherein the composition, upon chewing, remains free of bad odor and taste. 2. The composition as claimed in claim 1 wherein said aqueous phase comprises gelatin and carageenan. 3. The composition as claimed in claim 1 further comprising at least 1% wt. xylitol. 4. The composition as claimed in claim 1 further comprising a citrus flavor. 5. The composition as claimed in claim 1 wherein said aqueous phase comprises a water soluble vitamin. 6. The composition as claimed in claim 1 in animal, doll, vehicle, rod, strip or tube shape. 7. A package comprising an air-tight compartment containing one dose unit of a composition as claimed in claim 1. 8. The package as claimed in claim 7 in the form of a blister pack. 9. A method of treatment of a human by oral administration of an effective amount of an active agent in oil form or dissolved in an oil comprising administering said active agent in a chewable composition according to claim 1. 10. The method as claimed in claim 9 wherein said active agent is an analgesic. 11. The method as claimed in claim 9 wherein said active agent is a triglyceride. 12. The composition as claimed in claim 1, wherein said aqueous phase comprises gelatin in an amount of about 10% wt. of the aqueous phase.